Rosa & Co. announced today the publication of an article titled, "Virtual patients inspired by multiomics predict the efficacy of an anti-IFNα mAb in cutaneous lupus." Rosa & Co. co-published the article with Servier, Research and Development and GENYO Center for Genomics and Oncological research in iScience on January 6, 2025. To read the article: iScience journal article link.